We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

285A:TSEKioxia Holdings Corporation Analysis

Data as of 2026-08-17 - not real-time

¥61,840.00

Latest Price

9/10Risk

Risk Level: High

Executive Summary

At ¥61,840.00, KIOXIA HOLDINGS CORPORATION shows no decisive moving-average alignment, leaving the trend neutral. The last 30 days have lost 18.9%. Momentum indicators put RSI at 54.1 (neutral) with MACD reading bullish. Recent trading has carved out support near ¥36,020.00 and resistance around ¥68,700.00.
On valuation the read is overvalued — earnings multiple of 61.2 versus a 36.5 sector average, above the peer group. The average analyst target implies 80.2% above today's level. Revenue is growing at 415.5% on a 36.6% profit margin.
On a 1-10 scale the risk profile lands at 9 — high. With 30-day volatility of 156.7%, a beta of 1.92 and a maximum drawdown of 64.7%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
All three time horizons resolve to hold, carrying 2/10 conviction.

Top Market Events

Kioxia Corporation, a subsidiary of Kioxia Holdings Corporation TOKYO: 285A and Sandisk Corporation Nasdaq: SNDK today...Reuters1monKioxia shares slump 12% as AI-related stocks fallTOKYO, June 26 Reuters - Shares of Japanese chipmaker...Barron's1monKioxia Holdings Corp.Kioxia Holdings Corp. engages in the supervision and management of its subsidiaries...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 2/10

Key Factors

  • Trading above the 200-day average of 35137.96
  • MACD momentum is positive
  • 30-day price change of -18.9%

Medium Term

1–3 years
Neutral
Model confidence: 2/10

Key Factors

  • P/E of 61.2 versus sector average of 36.5
  • Trading above the 200-day average of 35137.96
  • Analyst targets imply +80.2% versus the current price

Long Term

> 3 years
Neutral
Model confidence: 2/10

Key Factors

  • P/E of 61.2 versus sector average of 36.5
  • Analyst targets imply +80.2% versus the current price
  • Profit margin of 36.6% is healthy

Key Metrics & Analysis

Financial Health

Revenue Growth415.50%
Profit Margin36.64%
P/E Ratio61.2
ROE87.11%
ROA34.33%
Debt/Equity34.84
P/B Ratio14.1
Op. Cash Flow¥1421.8B
Free Cash Flow¥857.6B
Industry P/E36.5

Technical Analysis

TrendNeutral
RSI54.1
Support¥36,020.00
Resistance¥68,700.00
MA 20¥51,804.50
MA 50¥70,886.00
MA 200¥35,137.97
MACDBullish
VolumeStable
Fear & Greed Index94.77

Valuation

Fair Value¥55,155.33
Target Price¥111,431.25
Upside/Downside80.19%
GradeOvervalued
TypeGrowth

Risk Assessment

Beta1.92
Volatility156.74%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.